Skip to content

Motor Control Mechanisms by CNS of Tuina in Patients With Lumbar Disk Herniation

A Mechanism of Tuina Treating Lumbar Disc Herniation Based of Central Nervous System Motion Control Modulating Reconstruction of Lumbar Stabilizer Function

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03475095
Enrollment
90
Registered
2018-03-23
Start date
2018-03-10
Completion date
2021-12-31
Last updated
2018-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disc, Herniated, Low Back Pain

Keywords

Low Back Pain, Tuina therapy, lumbar disc herniation, central motion control, functional magnetic resonanceimaging, effect mechanism, Chronic nonspecific low Back pain

Brief summary

Lumbar disk herniation (LDH)is a prevalent health problem around the world. It can cause symptoms of low back pain, numbness or weakness.The understanding of low back pain in traditional Chinese medicine(TCM) theoryunbalanced bones and musclesthat is consistent with the description of modern medicine on LDH function pathology. Tuina is one of Diagnosis and treatment methods in TCM which has been used as a noninvasive treatment of LDH. However, the mechanism of Tuina therapy in LDH is still unclear.The purpose of this study is to establish a platform of the therapeutic effect and mechanical effect of LDH in the treatment of LDH,explore the characteristics of Tuina by the motor control in lumbar CNS,observe the patterns and regularities in the function of related brain regionin of patients with acute or chronic LDH and reveal the mechanism of Tuina of improving the control of lumbar spine CNS movement.

Detailed description

Clinical researches has demonstrated the effectiveness of Tuina on lumbar disc herniation (LDH), but the mechanism remains unclear.The existing researches mainly focus on the mechanical mechanism of the local stability reconstruction of the lumbar spine. Our previous study found that LDH patients have lumbar CNS motion control disorder, and preliminary studies have shown that Tuina can improve the lumbar CNS motion control efficiency, also fMRI studies found that abnormal motion related brain areas had an active trend during the acute phase and a suppressed trend in the chronic period.Therefore,we hypothesize that Tuina could improve the lumbar CNS motion control in LDH patients, and could response to the effect of local mechanical lumbar as well as bidirectionally regulate the function of lumbar stabilizers, which facilitates the stable reconstruction of lumbar. This project will illuminate the effect of Tuina improving the lumbar CNS motion control by applying the latest fMRI, surface electromyography and data mining technology to the acute and chronic LDH patients with a combination of efficacy and experimental verification to reveal the mechanism of CNS bidirectional regulation of paraspinal muscle activity by the response of related brain regions to mechanical effects after Tuina on the lumbar. This project provides a new thinking to the research of the therapeutic mechanism of LDH, which is a scientific significance.

Interventions

OTHERTuina

Patients will receive Tuina therapies tiwce per week in one month.each time lasts about 20 minutes,a total of 4 weeks.

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* accord with the diagnostic criteria of lumbar disc herniation in the seventh edition of Surgery, and diagnosed by MRI, the course of acute patients ≤ 1 month, the course of chronic patients ≥ 3 months * Age:25~40 years old * VAS score ≥30/100 * Waist ODI index≥20% * Self-rating anxiety scale (SAS)\<59 points, Self-rating Depression Scale (SDS) \<53 points * BMI\<24 * Signed the Informed Consent Form

Exclusion criteria

* History of spinal surgery or history of severe spine trauma * Combined with other lumbar conditions may interfere with clinical outcomes (e.g. bone tuberculosis, tumors and severe osteoporosis) * Combines cardiovascular disease, blood system, digestive system and other serious medical diseases or psychosis * Women at childbearing age and of pregnancy desire during the study * combined with autoimmune diseases, allergy Sexual diseases, acute and chronic infectious diseases * Presence of any major physical or neurological illness * MRI contraindication * MRI showed nucleus pulposus free, cauda equina syndrome * vision loss, vestibular dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale (VAS)6 weeksAssessment of pain intensity before treatment of all patients,collate related data and statistically analyzed.
Oswestry Disability Index (ODI)6 weeksAssessment of symptoms and severity of low back pain
Biering-Sørensen test6 weeksAssessment of endurance of the lumbar paraspinal muscle
Rapid reaction time6 weeksMeasurement of rapid reaction time will be conducted in surface electromyo gram

Secondary

MeasureTime frameDescription
Visual analogue scale (VAS)12 weeksAssessment of pain intensity before treatment of all patients,collate related
Finite element analysis12 weeksIntervertebral disc biomechanical analysis
Biering-Sørensen test12 weeksAssessment of endurance of the lumbar paraspinal muscle
Oswestry Disability Index (ODI)12 weeksAssessment of symptoms and severity of low back pain
Cross sectional area of multifidus12 weeksMeasurement of Cross Sectional Area of Multifidus will be performed on MR images
Resting state functional magnetic resonance imaging and magnetic resonance spectroscopy12 weeksIdentification of brain activation in the motor area during Tuina.
Rapid reaction time12 weeksMeasurement of rapid reaction time will be conducted in surface electromyo gram

Countries

China

Contacts

Primary Contacthonggen Du, master
duhonggen1212@163.com+86-0571-87070217
Backup Contactkeding Shao, master
knail@163.com+86-0571-86613536

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026